(Pro)renin receptor [(P)RR], a receptor for renin and prorenin, was first cloned in 2002. Since then, the pathophysiological roles of(P)RR have been growing concerns.(P)RR binds renin and prorenin, with two important consequences, nonproteolytic activation of prorenin, leading to the tissue renin-angiotensin system activation and the intracellular signalings. It is now also known to play an important role as vacuolar H+-ATPase associated protein, involving in Wnt signaling, main component of embryonic development. Extracellular domain of full-length(P)RR is cleaved in golgi-complex forming soluble(P)RR [s(P)RR]. The s(P)RR is now possible to be measured in human blood and urine. It is now measured in different pathophysiological states, and recent study showed that elevated plasma s(P)RR levels in the early stage of pregnancies are associated with higher incidence of gestational diabetes mellitus later in the pregnancies. Plasma s(P)RR levels of neonates are known to be higher than that of adults. It was also shown that, increased s(P)RR concentrations in cord blood, associated with a lower small for gestational age birth likelihood. These data suggests the involvement of(P)RR in embryo’s growth. In thisreview article, we attempt to figure out the possible pathophysiological roles of the(P)RR in maternal glucose intolerance and embryo’s growth, through reviewing previous studies. (Pro) renin receptor [(P) RR], a receptor for renin and prorenin, was first cloned in 2002. Since then, the pathophysiological roles of (P) RR have been closely concerned. (P) RR binds renin and prorenin, with two important consequences, nonproteolytic activation of prorenin, leading to the tissue renin-angiotensin system activation and the intracellular signalings. It is now also known to play an important role as vacuolar H + -ATPase associated protein, involving in Wnt signaling, main component of embryonic development. Extracellular domain of full-length (P) RR is cleaved in golgi-complex forming soluble (P) RR [s (P) RR] It is now measured in different pathophysiological states, and recent study showed that elevated plasma s (P) RR levels in the early stage of pregnancies are associated with higher incidence of gestational diabetes mellitus later in the pregnancies. Plasma s (P) RR levels of neonates are known to be higher than tha t of adults. It was also shown in, increased s (P) RR concentrations in cord blood, associated with a lower small for gestational age birth likelihood. These data suggests the involvement of (P) RR in embryo’s growth. In this article view, we attempt to figure out the possible pathophysiological roles of the (P) RR in maternal glucose intolerance and embryo’s growth, through reviewing previous studies.